TINEA CORPORIS
Clinical trials for TINEA CORPORIS explained in plain language.
Never miss a new study
Get alerted when new TINEA CORPORIS trials appear
Sign up with your email to follow new studies for TINEA CORPORIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Which pill works best for stubborn ringworm? new study aims to find out
Disease control Recruiting nowThis study tests two oral antifungal drugs, fluconazole and itraconazole, in adults with ringworm that hasn't cleared up with creams. About 126 people aged 18-70 with persistent infection for at least 6 months will take one of the two medicines for 4 weeks. The goal is to see whi…
Matched conditions: TINEA CORPORIS
Phase: PHASE4 • Sponsor: Urooj Fatima • Aim: Disease control
Last updated May 15, 2026 11:53 UTC
-
Could the MMR vaccine beat tough fungal skin infections?
Disease control Recruiting nowThis study tests if injecting the MMR vaccine directly into stubborn fungal skin infections (tinea) can help clear them. It includes 50 people aged 10-60 whose infections did not improve with standard antifungal pills. Participants receive injections every 2 weeks for up to 6 wee…
Matched conditions: TINEA CORPORIS
Phase: NA • Sponsor: Abeer Mohamed Abdelaziz Elkholy • Aim: Disease control
Last updated May 07, 2026 18:40 UTC